Please provide your email address to receive an email when new articles are posted on . In a real-world retrospective study, researchers found mycophenolate mofetil treatment to be safe and effective ...
A phase 3 trial explored which treatment option for pemphigus vulgaris, a rare skin disease, resulted in better outcomes after 52 weeks. In patients with pemphigus vulgaris, rituximab was superior to ...
Mycophenolate mofetil is the preferred first-line treatment for lupus nephritis, although it is not superior to cyclophosphamide and long-term data are lacking Tacrolimus has equal efficacy to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results